Autocrine complement C3 inhibits IL-10-mediated cytotoxic properties of tumor-infiltrating CD8 T lymphocytes through complement receptors C3aR and C5aR1, and enhances melanoma and breast cancer growth (67). Here, C3 is linked to neoplasm.